{
    "clinical_study": {
        "@rank": "28460", 
        "acronym": "VERROUREA", 
        "arm_group": [
            {
                "arm_group_label": "Heparin lock", 
                "arm_group_type": "Placebo Comparator"
            }, 
            {
                "arm_group_label": "Citrate lock", 
                "arm_group_type": "Experimental"
            }
        ], 
        "brief_summary": {
            "textblock": "After obtaining written informed consent and inclusion, patients will be randomised into 2\n      groups for the type of dialysis catheter lock:\n\n        -  The first group will have a citrate lock\n\n        -  The second group will have a heparin lock Patients will be stratified according to the\n           centre and type of Renal Replacement Therapy (RRT) continuous or intermittent.\n\n      The daily surveillance of patients will be no different from the usual surveillance of\n      patients on Renal Replacement Therapy.\n\n      The hemodialysis catheters used will be specific Renal Replacement Therapy catheters.\n\n      The decision to withdraw the catheter will be made by the investigator and based on clinical\n      criteria (complications related to the catheter, termination of Renal Replacement Therapy\u2026)"
        }, 
        "brief_title": "Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU", 
        "condition": "Patients With Acute Renal Insufficiency", 
        "condition_browse": {
            "mesh_term": [
                "Acute Kidney Injury", 
                "Renal Insufficiency"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged > 18 years\n\n          -  Requiring RRT for acute renal insufficiency\n\n          -  For which a 1st non-tunneled catheter is placed\n\n          -  In the jugular or femoral position\n\n          -  After written informed consent has been obtained from the patient, a member of the\n             family or a person of trust\n\n        Exclusion Criteria:\n\n          -  Patient presenting active poorly controlled bleeding\n\n          -  Known allergy to citrate\n\n          -  Acute liver failure (Prothrombin level <30%)\n\n          -  Thrombopenia < 30 000/mm3\n\n          -  Known or suspected heparin-induced thrombopenia\n\n          -  Known systemic bacterial infection at the time the catheter is placed\n\n          -  catheter in the subclavicular position\n\n          -  Persons not covered by the national health insurance agency\n\n          -  Pregnant womens\n\n          -  Adults under guardianship"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "386", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01962116", 
            "org_study_id": "QUENOT DB 2012"
        }, 
        "intervention": [
            {
                "arm_group_label": "Citrate lock", 
                "intervention_name": "Citrate 4%", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Heparin lock", 
                "intervention_name": "unfractionated heparin", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Calcium heparin", 
                "Citric Acid", 
                "Heparin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "October 10, 2013", 
        "location": {
            "contact": {
                "email": "jean-pierre.quenot@chu-dijon.fr", 
                "last_name": "Jean-Pierre QUENOT", 
                "phone": "03.80.29.36.85"
            }, 
            "facility": {
                "address": {
                    "city": "Dijon", 
                    "country": "France", 
                    "zip": "21000"
                }, 
                "name": "CHU Dijon"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "2", 
        "official_title": "Citrate Versus Heparin for the Lock of Non-tunneled Hemodialysis Catheters in Patients Hospitalised in ICU = Multicentre, Controlled, Randomised Superiority Trial", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Agence Nationale de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Duration average of use without complication", 
            "safety_issue": "Yes", 
            "time_frame": "up to 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01962116"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Centre Hospitalier Universitaire Dijon", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Centre Hospitalier Universitaire Dijon", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label", 
        "study_type": "Interventional", 
        "verification_date": "October 2013"
    }
}